Fig. 3From: Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysisDisease-free survival (DFS). A < 4 weeks vs. 4–6 weeks. B < 4 weeks vs. > 6 weeks. C > 6 weeks vs. 4–6 weeksBack to article page